The neuroprotective effects of estrogen on the aging brain

Experimental Gerontology

Volumn 38, Issue 1-2, 2003, Pages 109-117

  Norbury, Ray ^a   Cutter, William J ^a   Compton, Jacqueline ^a   Robertson, Dene M ^a   Craig, Michael ^a   Whitehead, Malcolm ^b   Murphy, Declan G ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Acetylcholine; Aging; Alzheimer's disease; Cognition; Depression; Dopamine; Estrogen; Noradrenaline; Serotonin

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; NERVE GROWTH FACTOR; NEUROTRANSMITTER;

AGED; ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN MATURATION; BRAIN METABOLISM; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DOPAMINERGIC SYSTEM; ESTROGEN ACTIVITY; ESTROGEN THERAPY; GLUCOSE METABOLISM; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; MEDLINE; MENOPAUSAL SYNDROME; NERVE CELL MEMBRANE; NEUROPROTECTION; NORADRENERGIC SYSTEM; ONSET AGE; OVARIECTOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENESCENCE; SEROTONINERGIC SYSTEM; SEX CHROMOSOME; SEX DIFFERENCE; SPECIES COMPARISON; STROKE; SYNAPTOGENESIS;

AGED; AGING; ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR DISORDERS; DEMENTIA; DEPRESSION; DOPAMINE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MALE; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; NOREPINEPHRINE; SEROTONIN; SEX;

EID: 0037240528     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(02)00166-3     Document Type: Conference Paper

References (84)

1. Asthana S., Baker L.D., Craft S., Stanczyk F.Z., Veith R.C., Raskind M.A., Plymate S.R. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology. 57:2001;605-612.
2. Barrett-Connor E., Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA. 269:1993;2637-2641.
3. Beattie C.W., Rodgers C.H., Soyka L.F. Endocrinology. 91:1972;276-286.
4. Behl C., Widmann M., Trapp T., Holsboer F. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216:1995;473-482.
5. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C.J., Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51:1997;535-541.
6. Berman K.F., Schmidt P.J., Rubinow D.R., Danaceau M.A., Van Horn J.D., Esposito G., Ostrem J.L., Weinberger D.R. Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc. Natl Acad. Sci. USA. 94:1997;8836-8841.
7. Biegon A., McEwen B.S. Modulation by estradiol of serotonin receptors in brain. J. Neurosci. 2:1982;199-205.
8. Biegon A., Resches A., Snyder L., McEwen B.S. Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci. 32:1983;2015-2021.
9. Burns A., Murphy D. Protection against Alzheimer's disease? Lancet. 348:1996;420-421.
10. Campbell S., Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin. Obstet. Gynecol. 4:1977;31-47.
11. Cramer O.M., Parker C.R.J., Porter J.C. Estrogen inhibition of dopamine release into hyperphysical portal blood. Endocrinology. 104:1979;419-421.
12. Doraiswamy P.M., Krishen A., Martin W.L., Sylvester J., Garman R.L., Metz A., DeVeaugh-Geiss J. Gender, concurrent estrogen use and cognition in Alzheimer's disease. Int. J. Geriatr. Psychopharmacol. 1:1997;34-37.
13. Dubal D.B., Kashon M.L., Pettigrew L.C., Ren J.M., Finklestein S.P., Rau S.W., Wise P.M. Estradiol protects against ischemic injury. J. Cereb. Blood Flow Metab. 18:1998;1253-1258.
14. Duka T., Tasker R., McGowan J.F. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacologia. 149:2000;129-139.
15. Eberling J.L., Reed B.R., Coleman J.E., Jagust W.J. Effect of estrogen on cerebral glucose metabolism in postmenopausal women. Neurology. 55:2000;875-877.
16. Falkeborne M., Persson I., Terent A., Bergstrom R., Lithell H., Naessen T. Long term trends in incidence of and mortality from acute myocardial infarction and stroke in women, analyses of total first events and of deaths in the Uppsala Health Care Region, Sweden. Epidemiology. 7:1996;67-74.
17. Fillit H., Weinreb H., Cholst I., Luine V., McEwen B., Amador R., Zabriskie J. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology. 11:1986;337-345.
18. Frith C.D., Dowdy J., Ferrier I.N., Crow T.J. Selective impairment of paired associate learning after administration of a centrally-acting adrenergic agonist (clonidine). Psychopharmacology. 87:1985;490-493.
19. Gazzaley A.H., Weiland N.G., McEwen B.S., Morrison J.H. Differential regulations of NMDAR1 mRNA and protein by estradiol in the rat hippocampus. J. Neurosci. 16:1996;6830-6838.
20. Gordon J.H. Modulation of apomophine induced stereotypy by estrogen: time course and dose response. Brain Res. Bull. 5:1980;679-682.
21. Gordon J.H., Perry K.O. Pre- and postsynaptic neurochemical alterations following estrogen induced dopamine hypersensitivity. Brain Res. Bull. 10:1983;425-428.
22. Gould E., Woolley C.S., Frankfurt M., McEwen B.S. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J. Neurosci. 10:1990;1286-1291.
23. Green P.S., Gordon K., Simpkins J.W. Phenolic A ring requirement for the neuroprotective effects of steroids. J. Steroid Biochem. Mol. Biol. 63:1997;229-235.
24. Grodstein F., Stampfer M., Manson J. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog. Cardiovasc. Dis. 38:1995;199-210.
25. Grodstein F., Chen J., Pollen D.A., Albert M.S., Wilson R.S., Folstein M.F., Evans D.A., Stampfer M.J. Postmenopausal hormone therapy and cognitive function in healthy older women. J. Am. Geriatr. Soc. 48:2000;746-752.
26. Hackman B.W., Galbraith D. Six month study of estrogen therapy with piperazine oestrone sulphate and its effects on memory. Curr. Med. Res. Opin. 4:1977;21-27.
27. Hampson E. Estrogen-related variations in human spatial and articulatory-motor skills. Psychoneuroendocrinology. 15:1990;97-111.
28. Henderson V.W., Paganini-Hill A., Emanuel C.K., Dunn M.E., Buckwalter J.G. Estrogen replacement therapy in older women: comparisons between Alzheimer's disease cases and nondemented control subjects. Arch. Neurol. 51:1994;896-900.
29. Henderson V.W., Paganini-Hill A., Miller B.L., Elble R.J., Reyes P.F., Shoupe D., McCleary C.A., Klein R.A., Hake A.M., Farlow M.R. Estrogen for Alzheimer's disease in women-randomised, double-blind, placebo-controlled trial. Neurology. 54:2000;295-301.
30. Hersey R.M., Llojd T., MacLusky N.J., Weisz J. The catecholestrogen 2-hydroxyestradiol-17 alpha, is formed from estradiol-17 alpha by hypothalamic tissue in vitro and inhibits tyrosine hydroxylase. Endocrinology. 111:1982;1734-1736.
31. Honjo K., Tanaka K., Kashiwagi T., Urabe M., Okada H., Hayashi M., Hayashi K. Senile dementia-Alzheimer's type and estrogen. Horm. Metab. Res. 27:1995;204-207.
32. Jacobs D.M., Tang M.X., Stern Y., Sano M., Marder K., Bell K.L., Schofield P., Dooneief G., Gurland B., Mayeux R. Cognitive function in nondemented older women who took estrogen after menopause. Neurology. 50:1998;368-373.
33. Janowsky D.S., Davis J.M. Progesterone-estrogen effects on uptake and release of norepinephrine by synaptosomes. Life Sci. 9:1970;525-531.
34. Jarvik L. Human intelligence: sex differences. Acta Genet. Med. Gemellol. 24:1975;189-211.
35. Kaye J.A., DeCarli C.D., Luxenberg J.S., Rapoport S.I. The significance of age-related enlargement of the cerebral ventricles in healthy men and women measured by quantitative computed X-ray tomography. J. Am. Geriatr. Soc. 40:1992;223-225.
36. Klaiber E.L., Kobayashi Y., Broverman D.M., Hall F. Plasma monoamine oxidase activity in regularly menstruating women and in ammenorrhoeic women receiving cyclic treatment with estrogens and progestin. J. Clin. Endocrinol. Metab. 33:1971;630-638.
37. Kugler J., Seus R., Krauskopf R., Brecht H.M., Raschig A. Differences in psychic performance with guanfacine and clonidine in normotensive subjects. Br. J. Clin. Pharmacol. 10:1980;1S-80S.
38. Lindstrøm E., Boysen G., Nyboe J., Appleyard M. Stroke incidence in copenhagen 1976-1988. Stroke. 23:1992;28-32.
39. Luine V. Estradiol increases Choline Acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol. 89:1985;484-490.
40. Luine V.N., McEwen B.S. Effects of oestradiol on turnover of type A monoamine oxidase in brain. J. Neurochem. 28:1977;1221-1227.
41. Maki P.M., Resnick S.M. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol. Aging. 21:2000;373-383.
42. Maki P.M., Resnick S.M. Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. Neuroimage. 14:2001;789-801.
43. Marx J. Searching for drugs that combat Alzheimer's disease. Science. 273:1996;50-53.
44. McEwen B.S. Gonadal steroids: humoral modulators of nerve-cell function. Psychoneuroendocrinology. 16:1980;151-164.
45. McEwen B.S. Clinical review 108: the molecular and neuroanatomical basis for estrogen effects in the central nervous system. J. Clin. Endocrinol. Metab. 84:1999;1790-1797.
46. Mizoguchi K., Kunishita T., Chui D.H., Tabira T. Stress induced nertonal death in the hippocampus of castrated rats. Neurosci. Lett. 138:1992;157-160.
47. Moses E.L., Drevets W.C., Smith G., Mathis C.A., Kalro B.N., Butters M.A., Leondires M.P., Greer P.J., Lopresti B., Loucks T.L., Berga S.L. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol. Psychiatry. 48:2000;854-860.
48. Mulnard R.A., Cotman C.W., Kawas C., van Dyck C.H., Sano M., Doody R., Koss E., Pfeiffer E., Jin S., Gamst A., Grundman M., Thomas R., Thal J. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease, a randomised controlled trial. JAMA. 283:2000;1007-1015.
49. Murphy D.G., DeCarli C., Daly E., Haxby J.V., Allen G., White B.J., McIntosh A.R., Powell C.M., Horwitz B., Rapoport S.I. X-chromosome effects on female brains: a magnetic resonance imaging study of Turner's syndrome. Lancet. 342:1993;1197-1200.
50. Murphy D.G., DeCarli C., McIntosh A.R., Daly E., Mentis M.J., Pietrini P., Szczepanik J., Schapiro M.B., Grady C.L., Horwitz B., Rapoport S.I. Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch. Genet. Psychiatry. 53:1996;585-594.
51. Okhura T., Teshima Y., Isse K., Matsuda H., Inoue T., Sakai Y., Iwasaki N., Yaoi Y. Estrogen increases cerebral and cerebellar blood flows in postmenopausal women. Menopause. 2:1995;13-18.
52. Paganini-Hill A., Ross R.K., Henderson B.E. Postmenopausal oestrogen treatment and stroke: a prospective study. Br. Med. J. 297:1988;519-522.
53. Paul S.M., Axelrod J., Saavedra J.M., Skolnick P. Estrogen-induced efflux of endogenous catecholamines from the hypothalamus in vitro. Brain. Res. 178:1979;499-505.
54. Pedersen A., Lidegaard O., Kreiner S., Ottesen B. Hormone replacement therapy and risk of non-fatal stroke. Lancet. 350:1997;127-1283.
55. Pettinin D., Wingerd J., Pellegrin F., Ramcharan S. Risk of vascular disease in women: smoking, oral contraceptives, noncontraceptive estrogens and other factors. J. Am. Med. Assoc. 242:1979;1150-1154.
56. Phillips S.M., Sherwin B.B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology. 17:1992;485-495.
57. Phillips S.M., Sherwin B.B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology. 17:1992;485-495.
58. Rauramo L., Lagerspetz K., Engblom P., Punnonen R.T. The effect of castration and peroral estrogen therapy on some psychological functions. Front. Horm. Res. 3:1975;94-104.
59. Resnick S.M., Metter E.J., Zonderman A.B. Estrogen replacement therapy and longitudinal decline in visual memory: a possible protective effect? Neurology. 49:1997;1491-1497.
60. Resnick S.M., Maki P.M., Golski S., Kraut M.A., Zonderman A.B. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm. Behav. 34:1998;171-182.
61. Robertson D.M.W., Van Amelsvoort T., Daly E., Simmons A., Whitehead M., Morris R.G., Murphy K.C., Murphy D.G. Effects of estrogen replacement therapy on human brain aging: an in vivo 1H MRS study. Neurology. 57:2001;2114-2117.
62. Rosenberg S., Fausone V., Clark R. The role of estrogens as a risk factor for stroke in postmentopausal women. West. J. Med. 133:1980;292-296.
63. Salomaa V., Rasi V., Pekkanen J., Vahtera E., Jauhiainen M., Vartiainen E., Ehnholm C., Tuomilehto J., Myllyla G. Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors: the FINRISK hemostasis study. Arterioscler. Thromb. Vasc. Biol. 15:1995;1549-1555.
64. Sapolsky R.M., Plotsky P.M. Hypercortisolism and its possible neural bases. Biol. Psychiatry. 46:1989;1047-1051.
65. Schneider L.S., Farlow M.R., Henderson V.W., Pogoda J.M. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology. 46:1996;1580-1584.
66. Shaywitz S.E., Shaywitz B.A., Pugh K.R., Fulbright R.K., Skudlarski P., Mencl W.E., Constable R.T., Naftolin F., Palter S.F., Marchione K.E., Katz L., Shankweiler D.P., Fletcher J.M., Lacadie C., Keltz M., Gore J.C. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. J. Am. Med. Assoc. 281:1999;1197-1202.
67. Sherwin B.B. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology. 13:1988;345-357.
68. Sherwin B.B., Tulandi T. 'Add-back' estrogen reverses cognitive deficits induced by a gonadotropin releasing-hormone agonist in women with leiomyomata uteri. J. Clin. Endocrinol. Metab. 81:1996;2545-2549.
69. Simpkins J.W., Singh M., Bishop J. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol. Aging. 15:(Suppl. 2):1994.
70. Skoog I., Nilsson L., Palmertz B., Andreasson L.A., Svanborg A. A population based study of senile dementia in 85 year olds. N. Engl. J. Med. 1993:1993;153-158.
71. Smith Y.R., Minoshima S., Kuhl D.E., Zubieta J.K. Effects of long-term hormone therapy on cholinergic synaptic concentrations in healthy postmenopausal women. J. Clin. Endocrinol. Metab. 86:2001;679-684.
72. Speroff L. The effect of oestrogen-progestogen postmenopausal hormone replacement therapy on the cardiovascular system. Eur. J. Menopause. 3:1996;151-163.
73. Takeda S., Matsuzawa T. Age-related brain atrophy: a study with computed tomography. J. Gerentol. 40:1985;159-163.
74. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effects of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
75. Tonnaer J.A., Leinders T., van Delft A.M. Ovariectomy and subchronic oestradiol - 17Beta administration decrease dopamine D1 and D2 receptors in rat striatum. Psychoneuroendocrinology. 14:1989;469-476.
76. Toran-Allerand C.D. The estrogen/neurotrophin connection during neural development: is co-localization of estrogen receptor with the neurotrophins and their receptors biologically relevant? Dev. Neurosci. 18:1996;36.
77. Vacas M.I., Cardineli D.P. Effect of estradiol on alpha and beta-adrenoceptor density in medial basal hypothalamus, cerebral cortex and pineal gland of ovarectomized rats. Neurosci. Lett. 17:1980;73-77.
78. Van Amelsvoort T., Abel K.M., Robertson D.M.W., Daly E., Critchley H., Whitehead M., Murphy D.G.M. Prolactin response to D-fenfluramine in postmenopausal women on and off ERT: comparison with young women. Psychoneuroendocrinology. 26:2001;493-502.
79. Van Amelsvoort T., Murphy D.G.M., Robertson D., Daly E., Whitehead M., Abel K. Effects of long-term estrogen replacement therapy on growth hormone response to pyridostigmine in helathy postmenopausal women. Psychoneuroendocrinology. 28:2003;101-112.
80. Villneuve A., Cazejust T., Cote M. Estrogens in tardive dyskinesia in male psychiatric patients. Neuropsychobiology. 1980;145-151.
81. Walsh B., Schiff I. Vasomotor flushes. Ann. NY Acad. Sci. 592:1990;340-356.
82. Wang P.N., Liao S.Q., Liu R.S., Liu C.Y., Chao H.T., Lu S.R., Yu H.Y., Wang S.J., Liu H.C. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology. 54:2000;2061-2066.
83. Woolley C.S., Weiland N.G., McEwen B.S., Schwartzkroin P.A. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J. Neurosci. 17:1997;1848-1859.
84. Yaffe K., Krueger K., Sarkar S., Grady D., Barrett-Connor E., Cox D.E., Nickelsen T. Cognitive function in postmenopausal women treated with raloxifene. N. Engl. J. Med. 344:2001;1207-1213.